Tag: colitis

This 2008 preclinical study investigated the effects of naltrexone, an opioid receptor antagonist, on inflammatory bowel disease (IBD) in murine models. The findings demonstrated that naltrexone administration led to significant improvements in colitis symptoms, including reduced inflammation and mucosal damage. The proposed mechanism involves modulation of the immune response through